Xingge Xu is currently a research assistant and will start his PhD in Dr. Amine Kamen's group at McGill University. He has been working on the downstream processing of influenza vaccine and SARS-CoV-2 RBD protein production. He has experience with heat and mass transfer and the cell metabolism modeling of a bioreactor.